Zobrazeno 1 - 10
of 309
pro vyhledávání: '"B Avouac"'
Autor:
A Vaz Carneiro, John Hutton, Wendelin Schramm, B Avouac, M Dank, R Duncombe, Panos Kanavos, J Albanell, M Wartenberg, I Kössler, K Jahnz-Rozyk, K Podrazilova, A Fink-Wagner, F Spandonaro, Jennifer Gill
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Copyright © 2017 Published by Elsevier Inc.
Objectives: Interest in Real World Evidence (RWE), data not collected via traditional randomised controlled trials (RCT) used in different contexts, is increasing for market-access and reimbursement d
Objectives: Interest in Real World Evidence (RWE), data not collected via traditional randomised controlled trials (RCT) used in different contexts, is increasing for market-access and reimbursement d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a473ee82d1710f1f9d8b2680404ce6d5
https://hdl.handle.net/10451/40277
https://hdl.handle.net/10451/40277
Autor:
B. Avouac, Clementine Nordon, Frédéric Rouillon, B. Astruc, Franck Baylé, Lamiae Grimaldi-Bensouda, Lucien Abenhaim, Michel Rossignol, Jessica J Jalbert
Publikováno v:
Journal of Population Therapeutics and Clinical Pharmacology. 24
Background Long-acting injectable (LAI) atypical antipsychotics are associated with improved adherence and reduced relapse rates in schizophrenia but reminder-based interventions may further improve outcomes. Objectives To assess an institutional med
Autor:
Michael Schlander, Payam Abrishami, Antonio Sarría-Santamera, M Brougham, Monika Wagner, Charles D. Petrie, B Avouac, Roman Casciano, Lorenzo G. Mantovani, D Samaha, Paul Kind, Michele Tringali
Publikováno v:
Value in Health. 21:S52
Autor:
Soizic Courcier-Duplantier, Bruno Falissard, Pierre Fender, B. Arnould, B. Avouac, O. Chassany, B. Hamelin, G. Lapeyre, P. Lendresse, A. Leplège, M. Lièvre, H. Mathiex-Fortunet, G. Paintaud, M. Pigeon, A. Puech, R. Samoyeau, A. Spriet, G. Steinberg, C. Vilain
Publikováno v:
Therapies. 58:267-273
The use of subjective outcome measures for assessing drug efficacy varies according to the disease in question. Subjective outcome measures used to complement an objective outcome measure can clearly claim the status of a main outcome measure. The va
Autor:
Soizic Courcier-Duplantier, Bruno Falissard, Pierre Fender, B. Arnould, B. Avouac, O. Chassany, B. Hamelin, G. Lapeyre, P. Lendresse, A. Leplège, M. Lièvre, H. Mathiex-Fortunet, G. Paintaud, M. Pigeon, A. Puech, R. Samoyeau, A. Spriet, G. Steinberg, C. Vilain
Publikováno v:
Therapies. 58:259-265
L'utilisation de criteres subjectifs d'evaluation de l'efficacite est variable selon les pathologies. Les criteres subjectifs utilises en complement de criteres objectifs peuvent tout a fait pretendre au statut de critere principal d'efficacite. La v
Autor:
Frédéric Rouillon, B. Astruc, Jessica J Jalbert, Michel Rossignol, Lamiae Grimaldi-Bensouda, Lucien Abenhaim, B. David, R. Bennoune, Franck Baylé, B. Avouac
Publikováno v:
Value in Health. 17(3)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W, Dere, B, Avouac, M, Boers, M, Buxton, C, Christiansen, A, Dawson, C, Gennari, F, Guillemin, H, Lawaetz, H, Lawetz, F, Ornskov, I, Roumagnac, J Y, Reginster
Publikováno v:
Calcified Tissue International. 63:93-97
Autor:
Jacques Massol, Frédéric Rouillon, Anne-Marie Magnier, Pierre Engel, Lamiae Grimaldi-Bensouda, Lucien Abenhaim, B. Avouac, Gérard Duru, B. Bégaud, Michel Rossignol, Didier Guillemot, F. Lert
Publikováno v:
Value in Health. 15(4)
Autor:
J P, Devogelaer, R L, Dreiser, E, Abadie, B, Avouac, G, Bouvenot, J, Carbonell Abello, J M, Kaufman, B W, Koes, A, Laslop, E, Lemmel, F, Richy, S, Rozenberg, V, Tavares, J P, Valat, J Y, Reginster
Publikováno v:
Clinical and experimental rheumatology. 21(6)
In this paper we propose guidelines for clinical trials aimed at assessing the efficacy of drugs for acute non-specific low back pain (LBP) with or without radicular pain, preliminary to their approval and registration. To this end, consensus stateme